FDA Approves Freestyle Libre Flash
Insulin Nation
SEPTEMBER 27, 2017
On September 27th, the FDA announced that the Abbott Freestyle Libre Flash glucose monitoring system would be cleared to enter the U.S. marketplace. The Libre Flash differs from all other wearable glucose monitoring systems for people with diabetes in that it does not require fingerstick calibration and it utilizes a sensor that can be worn for up to 10 days.
Let's personalize your content